Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Tuberous Sclerosis 1Sleep Wake Disorders 1Pancreatic Neoplasms 1Clinical Stage I Esophageal Adenocarcinoma American Joint Committee on Cancer (AJCC) v8 1Carcinoma, Hepatocellular 1Biliary Tract Neoplasms 1

Interventions

Everolimus 18Sirolimus 15Cannabidiol 5radiprodil 3ganaxolone 3Vigabatrin 3Activator Appliances 3Melatonin 2exemestane 1dactolisib 1carbon-11 acetate 1Surveys and Questionnaires 1Simvastatin 1Sertraline 1Selective Serotonin Reuptake Inhibitors 1Propranolol 1Itraconazole 1Injections 1Fluid Therapy 1Doxycycline 1Curcumin 1Carbamazepine 1Calcitriol 1Aspirin 1Anticonvulsants 1Actigraphy 1Acceptance and Commitment Therapy 12-chloro-4-(1-(4-fluorophenyl)-2,5-dimethyl-1H-imidazol-4-ylethynyl)pyridine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Tuberous Sclerosis × Actigraphy × Clear all
NCT03326765 2018-10-17

Characterizing Sleep Disorders in Children and Adults With Tuberous Sclerosis Complex (TSC)

Universitair Ziekenhuis Brussel

Phase NA Unknown
60 enrolled

Sleep Wake Disorders, Tuberous Sclerosis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡